Theresa Anne Hadlock, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Facial Paralysis | 49 | 2015 | 345 | 12.090 |
Why?
|
Facial Nerve | 24 | 2015 | 277 | 4.840 |
Why?
|
Facial Nerve Injuries | 14 | 2015 | 64 | 4.310 |
Why?
|
Vibrissae | 15 | 2015 | 116 | 3.590 |
Why?
|
Smiling | 11 | 2015 | 72 | 3.360 |
Why?
|
Nerve Regeneration | 18 | 2015 | 791 | 2.490 |
Why?
|
Facial Muscles | 11 | 2015 | 159 | 2.150 |
Why?
|
Synkinesis | 5 | 2015 | 23 | 2.010 |
Why?
|
Free Tissue Flaps | 7 | 2014 | 327 | 1.740 |
Why?
|
Face | 9 | 2015 | 1017 | 1.700 |
Why?
|
Facial Expression | 13 | 2015 | 508 | 1.690 |
Why?
|
Recovery of Function | 14 | 2015 | 2985 | 1.270 |
Why?
|
Muscle, Skeletal | 12 | 2015 | 4925 | 1.210 |
Why?
|
Microsurgery | 7 | 2014 | 796 | 1.180 |
Why?
|
Blinking | 7 | 2014 | 133 | 1.050 |
Why?
|
Rats, Wistar | 16 | 2015 | 1850 | 0.980 |
Why?
|
Physical Stimulation | 5 | 2014 | 518 | 0.960 |
Why?
|
Video Recording | 9 | 2015 | 955 | 0.850 |
Why?
|
Facial Asymmetry | 3 | 2013 | 172 | 0.840 |
Why?
|
Nerve Transfer | 4 | 2015 | 125 | 0.770 |
Why?
|
Sciatic Nerve | 6 | 2005 | 613 | 0.760 |
Why?
|
Nasal Obstruction | 2 | 2015 | 159 | 0.730 |
Why?
|
Peripheral Nerves | 6 | 2012 | 475 | 0.710 |
Why?
|
Schwann Cells | 6 | 2009 | 196 | 0.700 |
Why?
|
Eyelid Diseases | 3 | 2012 | 157 | 0.700 |
Why?
|
Diagnosis, Computer-Assisted | 2 | 2015 | 707 | 0.650 |
Why?
|
Rats | 35 | 2014 | 23711 | 0.650 |
Why?
|
Quality of Life | 13 | 2015 | 13308 | 0.640 |
Why?
|
Eyelids | 4 | 2012 | 277 | 0.610 |
Why?
|
Movement | 6 | 2012 | 1474 | 0.600 |
Why?
|
Polyglycolic Acid | 5 | 2003 | 405 | 0.540 |
Why?
|
Polymers | 6 | 2005 | 1621 | 0.510 |
Why?
|
Neuromuscular Agents | 4 | 2015 | 148 | 0.510 |
Why?
|
Physical Therapy Modalities | 3 | 2015 | 536 | 0.490 |
Why?
|
Models, Animal | 5 | 2015 | 2117 | 0.490 |
Why?
|
Rhinoplasty | 2 | 2017 | 238 | 0.490 |
Why?
|
Bell Palsy | 1 | 2015 | 39 | 0.480 |
Why?
|
Photography | 4 | 2014 | 530 | 0.480 |
Why?
|
Nose Deformities, Acquired | 1 | 2015 | 44 | 0.480 |
Why?
|
Videotape Recording | 2 | 2013 | 337 | 0.460 |
Why?
|
Ear Auricle | 1 | 2014 | 31 | 0.460 |
Why?
|
Ear Cartilage | 1 | 2014 | 62 | 0.460 |
Why?
|
Rhytidoplasty | 1 | 2014 | 68 | 0.440 |
Why?
|
Tissue Engineering | 8 | 2014 | 1870 | 0.430 |
Why?
|
Polyethylene | 1 | 2014 | 186 | 0.420 |
Why?
|
Surgical Flaps | 6 | 2015 | 1669 | 0.410 |
Why?
|
Lactic Acid | 5 | 2003 | 1134 | 0.410 |
Why?
|
Fibrin Tissue Adhesive | 1 | 2012 | 86 | 0.410 |
Why?
|
Muscle Contraction | 2 | 2014 | 1201 | 0.400 |
Why?
|
Muscle Hypertonia | 1 | 2011 | 12 | 0.390 |
Why?
|
Botulinum Toxins, Type A | 3 | 2015 | 229 | 0.390 |
Why?
|
Random Allocation | 8 | 2014 | 2394 | 0.370 |
Why?
|
Neck Muscles | 1 | 2011 | 100 | 0.370 |
Why?
|
Parotid Neoplasms | 2 | 2009 | 157 | 0.370 |
Why?
|
Therapy, Computer-Assisted | 1 | 2013 | 267 | 0.370 |
Why?
|
Ultrasonography, Doppler, Color | 1 | 2012 | 231 | 0.360 |
Why?
|
Tissue Scaffolds | 2 | 2014 | 928 | 0.350 |
Why?
|
Biocompatible Materials | 4 | 2005 | 1689 | 0.350 |
Why?
|
Nimodipine | 1 | 2010 | 56 | 0.350 |
Why?
|
Sural Nerve | 2 | 2008 | 105 | 0.350 |
Why?
|
Botulinum Toxins | 5 | 2015 | 188 | 0.350 |
Why?
|
Muscular Atrophy | 1 | 2013 | 331 | 0.350 |
Why?
|
Lip Diseases | 1 | 2009 | 18 | 0.350 |
Why?
|
Neurofibromatosis 2 | 2 | 2013 | 385 | 0.340 |
Why?
|
Neurosurgical Procedures | 3 | 2013 | 2056 | 0.330 |
Why?
|
Lip | 4 | 2015 | 197 | 0.330 |
Why?
|
Eye | 1 | 2013 | 710 | 0.320 |
Why?
|
Autonomic Nervous System | 1 | 2014 | 697 | 0.320 |
Why?
|
Decompression, Surgical | 1 | 2014 | 604 | 0.310 |
Why?
|
Platinum | 1 | 2009 | 223 | 0.300 |
Why?
|
Paralysis | 1 | 2009 | 251 | 0.300 |
Why?
|
Physical Examination | 1 | 2014 | 1244 | 0.290 |
Why?
|
Prostheses and Implants | 4 | 2013 | 1273 | 0.290 |
Why?
|
Suture Techniques | 1 | 2012 | 790 | 0.290 |
Why?
|
Female | 56 | 2015 | 391270 | 0.290 |
Why?
|
Treatment Outcome | 24 | 2015 | 65017 | 0.280 |
Why?
|
Esthetics | 3 | 2015 | 326 | 0.280 |
Why?
|
Disease Models, Animal | 6 | 2014 | 18137 | 0.280 |
Why?
|
Physiology | 1 | 2007 | 112 | 0.270 |
Why?
|
Calcium Channel Blockers | 1 | 2010 | 694 | 0.270 |
Why?
|
Sciatic Neuropathy | 2 | 2009 | 75 | 0.270 |
Why?
|
Disease Management | 2 | 2014 | 2514 | 0.270 |
Why?
|
Intraoperative Complications | 1 | 2013 | 1186 | 0.260 |
Why?
|
Animals | 42 | 2015 | 167963 | 0.260 |
Why?
|
Head Movements | 1 | 2007 | 152 | 0.260 |
Why?
|
Immobilization | 1 | 2007 | 230 | 0.260 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2013 | 8950 | 0.260 |
Why?
|
Decanoates | 1 | 2005 | 55 | 0.260 |
Why?
|
Robotics | 1 | 2013 | 874 | 0.260 |
Why?
|
Biological Factors | 1 | 2006 | 157 | 0.250 |
Why?
|
Hypoglossal Nerve | 2 | 2004 | 100 | 0.250 |
Why?
|
Oculomotor Muscles | 1 | 2009 | 407 | 0.250 |
Why?
|
Tissue and Organ Harvesting | 1 | 2008 | 377 | 0.250 |
Why?
|
Follow-Up Studies | 13 | 2014 | 39261 | 0.240 |
Why?
|
Guided Tissue Regeneration | 1 | 2005 | 88 | 0.240 |
Why?
|
Male | 48 | 2015 | 359744 | 0.240 |
Why?
|
Rats, Inbred F344 | 6 | 2009 | 825 | 0.240 |
Why?
|
Adult | 32 | 2015 | 219994 | 0.230 |
Why?
|
Glycerol | 1 | 2005 | 276 | 0.230 |
Why?
|
Adolescent | 20 | 2015 | 87810 | 0.230 |
Why?
|
Motor Activity | 3 | 2014 | 2687 | 0.230 |
Why?
|
Internet | 2 | 2015 | 3078 | 0.230 |
Why?
|
Humans | 67 | 2017 | 760621 | 0.230 |
Why?
|
Tacrolimus | 1 | 2007 | 733 | 0.220 |
Why?
|
Algorithms | 5 | 2014 | 13981 | 0.220 |
Why?
|
Vascular Surgical Procedures | 2 | 2003 | 1475 | 0.220 |
Why?
|
Facial Nerve Diseases | 2 | 2013 | 49 | 0.220 |
Why?
|
Evidence-Based Medicine | 1 | 2015 | 3696 | 0.220 |
Why?
|
Middle Aged | 28 | 2015 | 220352 | 0.210 |
Why?
|
Surgical Wound Infection | 1 | 2012 | 1527 | 0.210 |
Why?
|
Postoperative Complications | 4 | 2012 | 15697 | 0.210 |
Why?
|
Massage | 3 | 2015 | 86 | 0.200 |
Why?
|
Retrospective Studies | 18 | 2015 | 80372 | 0.200 |
Why?
|
Diagnostic Imaging | 2 | 2013 | 3527 | 0.200 |
Why?
|
Severity of Illness Index | 8 | 2015 | 15840 | 0.200 |
Why?
|
Nerve Growth Factor | 1 | 2003 | 158 | 0.200 |
Why?
|
Surgery, Plastic | 1 | 2008 | 643 | 0.200 |
Why?
|
Muscle Denervation | 2 | 2013 | 60 | 0.190 |
Why?
|
Trismus | 1 | 2001 | 32 | 0.190 |
Why?
|
Software | 2 | 2013 | 4419 | 0.190 |
Why?
|
Mastoiditis | 1 | 2001 | 37 | 0.190 |
Why?
|
Young Adult | 12 | 2014 | 58741 | 0.190 |
Why?
|
Trigeminal Nerve | 2 | 2014 | 248 | 0.190 |
Why?
|
Prospective Studies | 12 | 2015 | 54303 | 0.180 |
Why?
|
Enoxaparin | 1 | 2003 | 397 | 0.180 |
Why?
|
Locomotion | 2 | 2001 | 387 | 0.170 |
Why?
|
Temporomandibular Joint | 1 | 2001 | 196 | 0.170 |
Why?
|
Iatrogenic Disease | 2 | 2013 | 538 | 0.170 |
Why?
|
Aged, 80 and over | 11 | 2015 | 58995 | 0.160 |
Why?
|
Aged | 20 | 2015 | 169152 | 0.160 |
Why?
|
Inosine | 1 | 1999 | 130 | 0.160 |
Why?
|
Pigment Epithelium of Eye | 1 | 1999 | 209 | 0.160 |
Why?
|
Child | 15 | 2015 | 79806 | 0.160 |
Why?
|
Equipment Design | 3 | 2013 | 3520 | 0.160 |
Why?
|
Endoscopy | 1 | 2008 | 1838 | 0.160 |
Why?
|
Implants, Experimental | 1 | 1998 | 99 | 0.150 |
Why?
|
Microcirculation | 1 | 2003 | 1278 | 0.150 |
Why?
|
Observer Variation | 3 | 2015 | 2601 | 0.150 |
Why?
|
Drug Delivery Systems | 2 | 2006 | 2221 | 0.150 |
Why?
|
Neuroma, Acoustic | 2 | 2013 | 459 | 0.150 |
Why?
|
Proprioception | 1 | 1999 | 133 | 0.150 |
Why?
|
Nasal Bone | 1 | 2017 | 57 | 0.140 |
Why?
|
Joint Diseases | 1 | 2001 | 457 | 0.140 |
Why?
|
Cell Transplantation | 1 | 1999 | 472 | 0.140 |
Why?
|
Tongue | 3 | 2006 | 404 | 0.140 |
Why?
|
Absorbable Implants | 1 | 1999 | 345 | 0.140 |
Why?
|
Streptococcal Infections | 1 | 2001 | 617 | 0.140 |
Why?
|
Fibrinolytic Agents | 2 | 2005 | 2167 | 0.140 |
Why?
|
Nerve Growth Factors | 1 | 1999 | 562 | 0.140 |
Why?
|
Cohort Studies | 7 | 2015 | 41335 | 0.140 |
Why?
|
Epithelium, Corneal | 1 | 1999 | 248 | 0.140 |
Why?
|
Fascia Lata | 1 | 2015 | 13 | 0.130 |
Why?
|
Hindlimb | 3 | 2005 | 510 | 0.130 |
Why?
|
Temporal Muscle | 1 | 2015 | 36 | 0.130 |
Why?
|
Porosity | 2 | 2014 | 349 | 0.120 |
Why?
|
Reproducibility of Results | 6 | 2015 | 20080 | 0.120 |
Why?
|
Immunosuppressive Agents | 1 | 2007 | 4166 | 0.120 |
Why?
|
Eye Protective Devices | 1 | 2014 | 33 | 0.120 |
Why?
|
Combined Modality Therapy | 4 | 2008 | 8552 | 0.120 |
Why?
|
Bioprosthesis | 1 | 1998 | 600 | 0.110 |
Why?
|
Myoblasts | 2 | 2006 | 232 | 0.110 |
Why?
|
Time Factors | 9 | 2015 | 40165 | 0.110 |
Why?
|
Postoperative Care | 2 | 2012 | 1479 | 0.110 |
Why?
|
Motion Therapy, Continuous Passive | 1 | 2013 | 11 | 0.110 |
Why?
|
Eyebrows | 1 | 2013 | 35 | 0.110 |
Why?
|
Graft Survival | 3 | 2014 | 3794 | 0.110 |
Why?
|
Skull | 2 | 2008 | 815 | 0.110 |
Why?
|
Hearing Tests | 1 | 2013 | 121 | 0.110 |
Why?
|
Ear | 1 | 2013 | 172 | 0.110 |
Why?
|
Infrared Rays | 1 | 2014 | 246 | 0.100 |
Why?
|
Neurologic Examination | 2 | 2015 | 916 | 0.100 |
Why?
|
Thrombosis | 2 | 2005 | 3052 | 0.100 |
Why?
|
Tissue Transplantation | 1 | 2012 | 128 | 0.100 |
Why?
|
Osteotomy | 1 | 2017 | 836 | 0.100 |
Why?
|
Acute Disease | 3 | 2008 | 7269 | 0.100 |
Why?
|
Ophthalmoplegia | 1 | 2012 | 168 | 0.090 |
Why?
|
Sheep | 1 | 2014 | 1441 | 0.090 |
Why?
|
Denervation | 2 | 2012 | 277 | 0.090 |
Why?
|
Sampling Studies | 1 | 2012 | 613 | 0.090 |
Why?
|
Tendons | 1 | 2015 | 552 | 0.090 |
Why?
|
Blepharoplasty | 1 | 2011 | 60 | 0.090 |
Why?
|
Equipment Failure Analysis | 1 | 2013 | 848 | 0.090 |
Why?
|
Anti-Dyskinesia Agents | 1 | 2010 | 24 | 0.090 |
Why?
|
Diagnostic Techniques, Ophthalmological | 1 | 2012 | 250 | 0.090 |
Why?
|
Mobius Syndrome | 1 | 2010 | 41 | 0.090 |
Why?
|
Thigh | 1 | 2011 | 240 | 0.090 |
Why?
|
Axotomy | 1 | 2009 | 71 | 0.080 |
Why?
|
Graft Rejection | 2 | 2014 | 4426 | 0.080 |
Why?
|
Microvessels | 1 | 2014 | 572 | 0.080 |
Why?
|
Massachusetts | 3 | 2014 | 8803 | 0.080 |
Why?
|
Microscopy, Electron, Scanning | 3 | 2003 | 941 | 0.080 |
Why?
|
Muscle Hypotonia | 1 | 2010 | 160 | 0.080 |
Why?
|
Biofeedback, Psychology | 1 | 2010 | 116 | 0.080 |
Why?
|
Titanium | 2 | 2013 | 484 | 0.080 |
Why?
|
Ecuador | 1 | 2008 | 61 | 0.080 |
Why?
|
Electric Stimulation | 2 | 2012 | 1735 | 0.080 |
Why?
|
Relaxation Therapy | 1 | 2010 | 179 | 0.080 |
Why?
|
Reference Values | 2 | 2014 | 4925 | 0.080 |
Why?
|
Nasal Cavity | 1 | 2010 | 304 | 0.080 |
Why?
|
Neural Conduction | 1 | 2010 | 441 | 0.080 |
Why?
|
Growth Cones | 1 | 2009 | 117 | 0.080 |
Why?
|
Peripheral Nervous System Neoplasms | 1 | 2009 | 133 | 0.080 |
Why?
|
Jaw Diseases | 1 | 2008 | 92 | 0.080 |
Why?
|
Nose Diseases | 1 | 2008 | 79 | 0.070 |
Why?
|
Ear, External | 1 | 2008 | 164 | 0.070 |
Why?
|
Dental Research | 1 | 2008 | 61 | 0.070 |
Why?
|
Medical Records Systems, Computerized | 1 | 2014 | 1191 | 0.070 |
Why?
|
Rats, Inbred Lew | 4 | 2006 | 1154 | 0.070 |
Why?
|
Dimyristoylphosphatidylcholine | 1 | 2007 | 26 | 0.070 |
Why?
|
1,2-Dipalmitoylphosphatidylcholine | 1 | 2007 | 41 | 0.070 |
Why?
|
Psychophysics | 1 | 2008 | 289 | 0.070 |
Why?
|
Glossectomy | 2 | 2006 | 60 | 0.070 |
Why?
|
Facial Bones | 1 | 2008 | 205 | 0.070 |
Why?
|
Tetracaine | 1 | 2007 | 34 | 0.070 |
Why?
|
Ocular Physiological Phenomena | 1 | 2007 | 67 | 0.070 |
Why?
|
Polyesters | 2 | 1999 | 372 | 0.070 |
Why?
|
Animals, Newborn | 2 | 2005 | 2672 | 0.070 |
Why?
|
Nose | 1 | 2010 | 519 | 0.070 |
Why?
|
Perioperative Care | 1 | 2014 | 1037 | 0.070 |
Why?
|
Disability Evaluation | 1 | 2014 | 1826 | 0.070 |
Why?
|
Hearing Loss | 1 | 2013 | 780 | 0.070 |
Why?
|
Ions | 1 | 2007 | 261 | 0.070 |
Why?
|
Injections, Intramuscular | 1 | 2007 | 553 | 0.070 |
Why?
|
Feedback | 1 | 2010 | 791 | 0.070 |
Why?
|
Neurology | 1 | 2014 | 779 | 0.060 |
Why?
|
Surface Properties | 3 | 2013 | 1161 | 0.060 |
Why?
|
Posture | 2 | 2001 | 953 | 0.060 |
Why?
|
Functional Laterality | 2 | 2012 | 2253 | 0.060 |
Why?
|
Membranes, Artificial | 1 | 2007 | 367 | 0.060 |
Why?
|
Linear Models | 1 | 2015 | 5877 | 0.060 |
Why?
|
Visual Perception | 1 | 2013 | 1374 | 0.060 |
Why?
|
Delayed Diagnosis | 1 | 2009 | 464 | 0.060 |
Why?
|
Pain Measurement | 1 | 2015 | 3528 | 0.060 |
Why?
|
Stress, Mechanical | 1 | 2010 | 1666 | 0.060 |
Why?
|
Injections, Subcutaneous | 2 | 2005 | 680 | 0.060 |
Why?
|
Rats, Sprague-Dawley | 2 | 2007 | 8158 | 0.060 |
Why?
|
Education, Medical, Graduate | 1 | 2017 | 2363 | 0.060 |
Why?
|
Cell Survival | 3 | 2006 | 5797 | 0.060 |
Why?
|
Eye Movements | 1 | 2008 | 508 | 0.060 |
Why?
|
Cells, Cultured | 5 | 2009 | 18957 | 0.060 |
Why?
|
Skin Transplantation | 1 | 2010 | 1083 | 0.060 |
Why?
|
Regression Analysis | 1 | 2014 | 6360 | 0.060 |
Why?
|
Monitoring, Physiologic | 1 | 2012 | 1784 | 0.060 |
Why?
|
Neuroprotective Agents | 1 | 2011 | 961 | 0.060 |
Why?
|
Pain | 1 | 1999 | 5066 | 0.060 |
Why?
|
Bone Transplantation | 1 | 2008 | 922 | 0.050 |
Why?
|
Bone Screws | 1 | 2007 | 530 | 0.050 |
Why?
|
Pilot Projects | 2 | 2017 | 8555 | 0.050 |
Why?
|
Sensitivity and Specificity | 2 | 2015 | 14660 | 0.050 |
Why?
|
Polyglactin 910 | 1 | 2003 | 55 | 0.050 |
Why?
|
Biodegradation, Environmental | 2 | 2003 | 218 | 0.050 |
Why?
|
PC12 Cells | 1 | 2003 | 317 | 0.050 |
Why?
|
Exercise Therapy | 1 | 2010 | 919 | 0.050 |
Why?
|
Electric Stimulation Therapy | 1 | 2008 | 613 | 0.050 |
Why?
|
Workload | 1 | 2008 | 847 | 0.050 |
Why?
|
Radiography | 1 | 2013 | 6965 | 0.050 |
Why?
|
Biopolymers | 1 | 2003 | 184 | 0.050 |
Why?
|
Materials Testing | 1 | 2005 | 862 | 0.050 |
Why?
|
Peripheral Nervous System | 1 | 2003 | 151 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2015 | 12159 | 0.050 |
Why?
|
Behavior, Animal | 1 | 2010 | 1866 | 0.050 |
Why?
|
Societies, Medical | 1 | 2014 | 3905 | 0.050 |
Why?
|
Patient Satisfaction | 2 | 2011 | 3448 | 0.050 |
Why?
|
Neck | 1 | 2005 | 731 | 0.040 |
Why?
|
Child, Preschool | 4 | 2015 | 42063 | 0.040 |
Why?
|
Risk Assessment | 3 | 2015 | 24123 | 0.040 |
Why?
|
Stem Cell Transplantation | 1 | 2009 | 1599 | 0.040 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2003 | 542 | 0.040 |
Why?
|
Microspheres | 1 | 2003 | 787 | 0.040 |
Why?
|
Otologic Surgical Procedures | 1 | 2001 | 149 | 0.040 |
Why?
|
Serum Albumin | 1 | 2003 | 674 | 0.040 |
Why?
|
Patient Education as Topic | 1 | 2010 | 2315 | 0.040 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2005 | 708 | 0.040 |
Why?
|
Delayed-Action Preparations | 1 | 2003 | 961 | 0.040 |
Why?
|
Head | 1 | 2005 | 922 | 0.040 |
Why?
|
Pliability | 1 | 1998 | 58 | 0.040 |
Why?
|
Forecasting | 1 | 2008 | 2932 | 0.040 |
Why?
|
Cell Adhesion | 1 | 2005 | 3094 | 0.040 |
Why?
|
Biomedical Engineering | 1 | 2000 | 289 | 0.040 |
Why?
|
Femoral Artery | 1 | 2003 | 835 | 0.040 |
Why?
|
Drug Carriers | 1 | 2003 | 709 | 0.040 |
Why?
|
Models, Theoretical | 1 | 2010 | 3562 | 0.040 |
Why?
|
Scalp | 1 | 2001 | 389 | 0.040 |
Why?
|
Accessory Nerve | 1 | 1998 | 11 | 0.040 |
Why?
|
Incidence | 2 | 2014 | 21392 | 0.040 |
Why?
|
Mass Screening | 1 | 2014 | 5423 | 0.040 |
Why?
|
Heparin | 1 | 2005 | 1652 | 0.040 |
Why?
|
Carcinoma | 1 | 2009 | 2331 | 0.040 |
Why?
|
Collagen | 2 | 2009 | 2636 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2013 | 8056 | 0.040 |
Why?
|
Neurodegenerative Diseases | 1 | 2006 | 1084 | 0.040 |
Why?
|
Cattle | 1 | 2003 | 3847 | 0.040 |
Why?
|
Regeneration | 1 | 2006 | 1506 | 0.040 |
Why?
|
Risk Factors | 2 | 2015 | 74359 | 0.040 |
Why?
|
Diagnosis, Differential | 1 | 2012 | 12965 | 0.030 |
Why?
|
Tight Junctions | 1 | 1999 | 315 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2003 | 3804 | 0.030 |
Why?
|
Stem Cells | 1 | 2009 | 3523 | 0.030 |
Why?
|
Transplantation, Autologous | 1 | 2000 | 2116 | 0.030 |
Why?
|
Imaging, Three-Dimensional | 1 | 2008 | 4048 | 0.030 |
Why?
|
Anastomosis, Surgical | 1 | 1998 | 983 | 0.030 |
Why?
|
Detergents | 1 | 1994 | 235 | 0.030 |
Why?
|
Micelles | 1 | 1994 | 192 | 0.030 |
Why?
|
Gait | 1 | 1999 | 812 | 0.030 |
Why?
|
False Negative Reactions | 1 | 2014 | 573 | 0.030 |
Why?
|
Chronic Disease | 1 | 2008 | 9287 | 0.030 |
Why?
|
Head and Neck Neoplasms | 2 | 2005 | 2882 | 0.030 |
Why?
|
Aspirin | 1 | 2005 | 3364 | 0.030 |
Why?
|
Cadaver | 1 | 2017 | 1345 | 0.030 |
Why?
|
Rabbits | 1 | 1999 | 4773 | 0.030 |
Why?
|
Axons | 1 | 2001 | 1673 | 0.030 |
Why?
|
Prevalence | 1 | 2009 | 15687 | 0.020 |
Why?
|
Adsorption | 2 | 2007 | 198 | 0.020 |
Why?
|
Actins | 1 | 1999 | 2049 | 0.020 |
Why?
|
False Positive Reactions | 1 | 2014 | 956 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 1999 | 1664 | 0.020 |
Why?
|
Walking | 1 | 1999 | 1189 | 0.020 |
Why?
|
Prosthesis Design | 1 | 1998 | 2135 | 0.020 |
Why?
|
Automation | 1 | 2014 | 580 | 0.020 |
Why?
|
Phosphoproteins | 1 | 1999 | 2440 | 0.020 |
Why?
|
Electromyography | 1 | 2015 | 1388 | 0.020 |
Why?
|
Education, Medical, Continuing | 1 | 2015 | 830 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2005 | 10446 | 0.020 |
Why?
|
Cartilage | 1 | 2013 | 806 | 0.020 |
Why?
|
Fluorescence | 2 | 2007 | 751 | 0.020 |
Why?
|
Anticoagulants | 1 | 2005 | 4897 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2007 | 22053 | 0.020 |
Why?
|
Swine | 1 | 1999 | 5899 | 0.020 |
Why?
|
Brain Neoplasms | 1 | 2009 | 8986 | 0.020 |
Why?
|
Anesthetics, Local | 1 | 1994 | 1001 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 2009 | 869 | 0.020 |
Why?
|
Laminin | 1 | 2009 | 405 | 0.020 |
Why?
|
Chick Embryo | 1 | 2009 | 981 | 0.020 |
Why?
|
Neurites | 1 | 2009 | 390 | 0.020 |
Why?
|
Ganglia, Spinal | 1 | 2009 | 523 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 1 | 2009 | 20509 | 0.020 |
Why?
|
Proteoglycans | 1 | 2009 | 801 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2014 | 6238 | 0.020 |
Why?
|
Sensory Receptor Cells | 1 | 2009 | 509 | 0.010 |
Why?
|
Coloring Agents | 1 | 2006 | 562 | 0.010 |
Why?
|
Sensation | 1 | 2005 | 331 | 0.010 |
Why?
|
Stainless Steel | 1 | 2003 | 79 | 0.010 |
Why?
|
Myofibrils | 1 | 2003 | 141 | 0.010 |
Why?
|
Drug Combinations | 1 | 2009 | 2025 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2001 | 7408 | 0.010 |
Why?
|
Carbon | 1 | 2006 | 669 | 0.010 |
Why?
|
Neurogenesis | 1 | 2009 | 856 | 0.010 |
Why?
|
Membrane Proteins | 1 | 1999 | 7850 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2009 | 36290 | 0.010 |
Why?
|
Nitrogen | 1 | 2003 | 350 | 0.010 |
Why?
|
Thermodynamics | 1 | 2003 | 599 | 0.010 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2014 | 3340 | 0.010 |
Why?
|
Facial Neoplasms | 1 | 2001 | 125 | 0.010 |
Why?
|
Hematoma | 1 | 2005 | 769 | 0.010 |
Why?
|
United States | 1 | 2008 | 72461 | 0.010 |
Why?
|
Extremities | 1 | 2005 | 867 | 0.010 |
Why?
|
Microscopy | 1 | 2005 | 885 | 0.010 |
Why?
|
Staining and Labeling | 1 | 2003 | 1089 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2011 | 10827 | 0.010 |
Why?
|
Disease Progression | 1 | 2015 | 13502 | 0.010 |
Why?
|
Cholesterol | 1 | 2007 | 2924 | 0.010 |
Why?
|
Hair | 1 | 2001 | 497 | 0.010 |
Why?
|
Alopecia | 1 | 2001 | 414 | 0.010 |
Why?
|
Internship and Residency | 1 | 2017 | 5870 | 0.010 |
Why?
|
Carcinoma, Basal Cell | 1 | 2001 | 559 | 0.010 |
Why?
|
Osteosarcoma | 1 | 2001 | 897 | 0.010 |
Why?
|
Cell Line | 1 | 2009 | 15620 | 0.010 |
Why?
|
Reoperation | 1 | 2005 | 4291 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2003 | 3765 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2009 | 11481 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2001 | 4024 | 0.000 |
Why?
|
Cell Membrane | 1 | 1994 | 3682 | 0.000 |
Why?
|
Melanoma | 1 | 2001 | 5697 | 0.000 |
Why?
|